MAGSENSE

Serial Number 88209721
602

Registration Progress

Application Filed
Nov 28, 2018
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

MAGSENSE

Basic Information

Serial Number
88209721
Filing Date
November 28, 2018
Abandonment Date
September 5, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Sep 18, 2019
Classes
005

Rights Holder

Imagion Biosystems, Inc.

03
Address
10355 Science Center Drive, Suite 210
San Diego, CA 92121

Ownership History

Imagion Biosystems, Inc.

Original Applicant
03
San Diego, CA

Legal Representation

Attorney
V Gerald Grafe

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

8 events
Date Code Type Description Documents
Sep 19, 2019 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Sep 18, 2019 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Sep 18, 2019 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Mar 4, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 4, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 4, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 27, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 17, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Preparations containing superparamagnetic nanoparticles for medical use in the nature of diagnostic preparations that are introduced into a human body and measured with one or more of medical measurement instruments, magnetic measurement instruments, or ultrasound instruments; preparations containing superparamagnetic nanoparticles for medical use in that are introduced into a human body and measured with one or more of medical measurement instruments, magnetic measurement instruments, or ultrasound instruments for detecting cancer; syringes prefilled with preparations containing superparamagnetic nanoparticles for medical use in in the nature of diagnostic preparations that are introduced into a human body and measured with one or more of medical measurement instruments, magnetic measurement instruments, or ultrasound instruments; syringes prefilled with preparations containing superparamagnetic nanoparticles for medical use in that are introduced into a human body and measured with one or more of medical measurement instruments, magnetic measurement instruments, or ultrasound instruments for detecting cancer; kits containing preparations containing superparamagnetic nanoparticles for medical use in in the nature of diagnostic preparations that are introduced into a human body and measured with one or more of medical measurement instruments, magnetic measurement instruments, or ultrasound instruments, and also containing syringes prefilled with such preparations; kits containing preparations containing superparamagnetic nanoparticles for medical use in that are introduced into a human body and measured with one or more of medical measurement instruments, magnetic measurement instruments, or ultrasound instruments for detecting cancer; cancer test kits containing preparations containing superparamagnetic nanoparticles for medical use in in the nature of diagnostic preparations that are introduced into a human body and measured with one or more of medical measurement instruments, magnetic measurement instruments, or ultrasound instruments; cancer test kits containing preparations containing superparamagnetic nanoparticles for medical use in that are introduced into a human body and measured with one or more of medical measurement instruments, magnetic measurement instruments, or ultrasound instruments for detecting cancer; and medical instrument systems, used for in vivo medical imaging or for the diagnosis or screening of cancer, for determination of one or more of the presence, the location, and the quantity of one or more of cells, cancerous growths, and proteins in the human body, comprising magnetic sensors sensitive to nanoparticles introduced into the human body; all of the foregoing not for use in diagnostic testing for cardiovascular diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005